Inhibition of Eukaryotic Translation Initiation by the Marine Natural Product Pateamine A

Altmann, 1993, A Saccharomyces cerevisiae homologue of mammalian translation initiation factor 4B contributes to RNA helicase activity, EMBO J., 12, 3997, 10.1002/j.1460-2075.1993.tb06077.x Anthony, 1992, Analysis of 40 S and 80 S complexes with mRNA as measured by sucrose density gradients and primer extension inhibition, J. Biol. Chem., 267, 1554, 10.1016/S0021-9258(18)45981-9 Bordeleau, 2005, Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation, Proc. Natl. Acad. Sci. USA, 102, 10460, 10.1073/pnas.0504249102 Caruthers, 2000, Crystal structure of yeast initiation factor 4A, a DEAD-box RNA helicase, Proc. Natl. Acad. Sci. USA, 97, 13080, 10.1073/pnas.97.24.13080 Coppolecchia, 1993, A new yeast translation initiation factor suppresses a mutation in the eIF-4A RNA helicase, EMBO J., 12, 4005, 10.1002/j.1460-2075.1993.tb06078.x Fischer, 1989, Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins, Nature, 337, 476, 10.1038/337476a0 Gilks, 2004, Stress granule assembly is mediated by prion-like aggregation of TIA-1, Mol. Biol. Cell, 15, 5383, 10.1091/mbc.E04-08-0715 Gingras, 1999, eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation, Annu. Rev. Biochem., 68, 913, 10.1146/annurev.biochem.68.1.913 Griffith, 1997, Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin, Chem. Biol., 4, 461, 10.1016/S1074-5521(97)90198-8 Grifo, 1984, RNA-stimulated ATPase activity of eukaryotic initiation factors, J. Biol. Chem., 259, 8648, 10.1016/S0021-9258(17)39779-X Harding, 1989, A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase, Nature, 341, 758, 10.1038/341758a0 Heitman, 1991, Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast, Science, 253, 905, 10.1126/science.1715094 Hunt, 1999, Unr, a cellular cytoplasmic RNA-binding protein with five cold-shock domains, is required for internal initiation of translation of human rhinovirus RNA, Genes Dev., 13, 437, 10.1101/gad.13.4.437 Kapp, 2004, The molecular mechanics of eukaryotic translation, Annu. Rev. Biochem., 73, 657, 10.1146/annurev.biochem.73.030403.080419 Katz, 2005, Translation and protein synthesis: macrolides, Chem. Rev., 105, 499, 10.1021/cr030107f Kedersha, 2002, Stress granules: sites of mRNA triage that regulate mRNA stability and translatability, Biochem. Soc. Trans., 30, 963, 10.1042/bst0300963 Kedersha, 2002, Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules, Mol. Biol. Cell, 13, 195, 10.1091/mbc.01-05-0221 Korneeva, 2005, Interaction between the NH2-terminal domain of eIF4A and the central domain of eIF4G modulates RNA-stimulated ATPase activity, J. Biol. Chem., 280, 1872, 10.1074/jbc.M406168200 Liu, 1993, FK506 and cyclosporin, molecular probes for studying intracellular signal transduction, Immunol. Today, 14, 290, 10.1016/0167-5699(93)90048-P Liu, 1991, Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes, Cell, 66, 807, 10.1016/0092-8674(91)90124-H Lorsch, 1998, DEAD box protein eIF4A. 1. A minimal kinetic and thermodynamic framework reveals coupled binding of RNA and nucleotide, Biochemistry, 37, 2180, 10.1021/bi972430g Lorsch, 1998, DEAD box protein eIF4A. 2. A cycle of nucleotide and RNA-dependent conformational changes, Biochemistry, 37, 2194, 10.1021/bi9724319 Matsuda, 2000, Molecular cloning and characterization of human MAWD, a novel protein containing WD-40 repeats frequently overexpressed in breast cancer, Cancer Res., 60, 13 Naranda, 1994, Two structural domains of initiation factor eIF-4B are involved in binding to RNA, J. Biol. Chem., 269, 14465, 10.1016/S0021-9258(17)36646-2 Nielsen, 1988, The mouse protein synthesis initiation factor 4A gene family includes two related functional genes which are differentially expressed, EMBO J., 7, 2097, 10.1002/j.1460-2075.1988.tb03049.x Northcote, 1991, Pateamine: a potent cytotoxin from the New Zealand marine sponge, Mycale sp, Tetrahedron Lett., 32, 6411, 10.1016/0040-4039(91)80182-6 Novac, 2004, Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen, Nucleic Acids Res., 32, 902, 10.1093/nar/gkh235 Pestka, 1977 Pestova, 2002, The roles of individual eukaryotic translation initiation factors in ribosomal scanning and initiation codon selection, Genes Dev., 16, 2906, 10.1101/gad.1020902 Pestova, 1998, A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs, Genes Dev., 12, 67, 10.1101/gad.12.1.67 Pestova, 2001, Molecular mechanisms of translation initiation in eukaryotes, Proc. Natl. Acad. Sci. USA, 98, 7029, 10.1073/pnas.111145798 Prevot, 2003, Conducting the initiation of protein synthesis: the role of eIF4G, Biol. Cell., 95, 141, 10.1016/S0248-4900(03)00031-5 Raught, 2004, Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases, EMBO J., 23, 1761, 10.1038/sj.emboj.7600193 Ray, 1985, ATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors, J. Biol. Chem., 260, 7651, 10.1016/S0021-9258(17)39658-8 Rocak, 2004, DEAD-box proteins: the driving forces behind RNA metabolism, Nat. Rev. Mol. Cell Biol., 5, 232, 10.1038/nrm1335 Rogers, 2001, Further characterization of the helicase activity of eIF4A. Substrate specificity, J. Biol. Chem., 276, 12598, 10.1074/jbc.M007560200 Rogers, 2001, Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F, J. Biol. Chem., 276, 30914, 10.1074/jbc.M100157200 Rogers, 2002, eIF4A: the godfather of the DEAD box helicases, Prog. Nucleic Acid Res. Mol. Biol., 72, 307, 10.1016/S0079-6603(02)72073-4 Romo, 1998, Total synthesis and immunosuppressive activity of (−)-pateamine A and related compounds: implementation of a β-lactam-based macrocyclization, J. Am. Chem. Soc., 120, 12237, 10.1021/ja981846u Romo, 2004, Evidence for separate binding and scaffolding domains in the immunosuppressive and antitumor marine natural product, pateamine a: design, synthesis, and activity studies leading to a potent simplified derivative, J. Am. Chem. Soc., 126, 10582, 10.1021/ja040065s Rozen, 1990, Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F, Mol. Cell. Biol., 10, 1134, 10.1128/MCB.10.3.1134 Schreiber, 1992, The mechanism of action of cyclosporin A and FK506, Immunol. Today, 13, 136, 10.1016/0167-5699(92)90111-J Shen, 1997, Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients, Blood, 89, 3354, 10.1182/blood.V89.9.3354 Siekierka, 1989, A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin, Nature, 341, 755, 10.1038/341755a0 Sonenberg, 1978, A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5′-terminal cap in mRNA, Proc. Natl. Acad. Sci. USA, 75, 4843, 10.1073/pnas.75.10.4843 Svitkin, 2001, The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure, RNA, 7, 382, 10.1017/S135583820100108X Vazquez, 1979, Inhibitors of protein biosynthesis, Mol. Biol. Biochem. Biophys., 30, 1, 10.1007/978-3-642-81309-2_1 Yoder-Hill, 1993, The p46 subunit of eukaryotic initiation factor (eIF)-4F exchanges with eIF-4A, J. Biol. Chem., 268, 5566, 10.1016/S0021-9258(18)53358-5